BAUSCH + LOMB LUMIFY BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION 0.025% REDNESS RELIEVER EYE DROPS
Live / Allowed — Published for opposition (as of 15 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 26 Jan 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99615143
- Mark type
- Design + words
- Filed
- 26 Jan 2026
- Published for opposition
- 15 Sept 2026
- Attorney of record
- Robert J. Gorman
Goods and services
- Class 005 — Pharmaceuticals: Eye drops; Ophthalmic preparations
Owner
- Bausch & Lomb Incorporated, Rochester, NY, US
- Bausch & Lomb Incorporated, Rochester, NY, US
Prosecution history
- 15 Sept 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Sept 2026 — PUBLISHED FOR OPPOSITION
- 09 Sept 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Aug 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Aug 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Aug 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Aug 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Jun 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Jun 2026 — NON-FINAL ACTION E-MAILED
- 23 Jun 2026 — NON-FINAL ACTION WRITTEN
- 23 Jun 2026 — LETTER OF PROTEST EVIDENCE REVIEWED - ACTION TAKEN
- 23 Jun 2026 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 17 Jun 2026 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 17 Jun 2026 — LETTER OF PROTEST EVIDENCE FORWARDED
- 17 Jun 2026 — WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST